Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire

Stock Information for Evofem Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Evofem Biosciences Inc.

Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE
Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update
Evofem Announces Voting Results from Special Meeting of Stockholders
Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates
Evofem Biosciences Honors World Contraception Day
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MLNK, BFIN, MRCC, EVFM on Behalf of Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - EVFM, MRCC, MLNK, and BFIN
Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.